- cafead   Oct 04, 2022 at 10:52: AM
via Clinical trial planning is shifting towards the patient more than ever before. The industry’s interest in decentralised clinical trials (DCTs) is on the rise after seeing that many logistical and geographical obstacles could be overcome during the Covid-19 pandemic. However, one of the key elements supporting trial decentralisation —digital tech—does not account for the technological divide amongst participants of different ages, races, and economic statuses.
article source
article source